Mesenchymal glioma stem cells trigger vasectasia—distinct neovascularization process stimulated by extracellular vesicles carrying EGFR
0303 health sciences
Brain Neoplasms
Science
Q
Endothelial Cells
Glioma
Article
ErbB Receptors
Mice
Extracellular Vesicles
03 medical and health sciences
Neoplastic Stem Cells
Humans
Animals
Glioblastoma
DOI:
10.1038/s41467-024-46597-x
Publication Date:
2024-04-03T09:02:54Z
AUTHORS (11)
ABSTRACT
Abstract Targeting neovascularization in glioblastoma (GBM) is hampered by poor understanding of the underlying mechanisms and unclear linkages to tumour molecular landscapes. Here we report that different subtypes human glioma stem cells (GSC) trigger distinct endothelial responses involving either angiogenic or circumferential vascular growth (vasectasia). The latter process selectively triggered mesenchymal (but not proneural) GSCs mediated a subset extracellular vesicles (EVs) able transfer EGFR/EGFRvIII transcript cells. Inhibition expression phosphorylation EGFR cells, pharmacologically (Dacomitinib) genetically (gene editing), abolishes their EV vitro disrupts vasectasia vivo. Therapeutic inhibition markedly extends anticancer effects VEGF blockade mice, coupled with abrogation prolonged survival. Thus, driven intercellular oncogenic may represent new therapeutic target GBMs.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (14)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....